Senior Medical Director, Pharmacovigilance and Safety
Oruka Therapeutics
Senior Medical Director, Pharmacovigilance and Safety
Oruka Therapeutics
Clinical-stage antibody therapies for psoriasis
About Us:
Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com
As we build our core team, we're seeking top talent in different functional areas who are not just looking for a job, but an opportunity to be part of something bigger. Someone who is passionate about making a difference and eager to contribute to establishing an engaged, inclusive, and positive company culture.
Job Title: Senior Medical Director, Pharmacovigilance and Safety
Location: Remote OR Hybrid 3 days/week if located near office in either Waltham, MA or Menlo Park, CA will be required.
Role Overview:
Oruka is seeking an experienced, collaborative pharmacovigilance leader to provide medical and scientific safety oversight for Oruka’s investigational products. The Senior Medical Director, Pharmacovigilance and Safety will lead safety activities and processes, oversee Oruka’s pharmacovigilance vendors, and ensure continuous assessment of each product's safety profile and benefit-risk balance. This role will also serve as the medical safety expert on cross-functional development teams, working closely with internal and external stakeholders to ensure compliance with regulations and guidelines, contribute to safety regulatory documents, and protect participant safety.
The successful candidate will combine strong clinical judgment and pharmacovigilance expertise with a team-oriented approach suited to a growing biotechnology company. The role will also help develop Oruka’s pharmacovigilance infrastructure, processes, governance, and vendor partnerships as the portfolio advances through clinical development and toward registration.
Key Responsibilities:
Product Safety Leadership and Risk Management
Medical Safety Oversight
Clinical Development and Regulatory Support
Pharmacovigilance Infrastructure and External Partnerships
Required Qualifications:
Compensation:
We're looking forward to hearing how you can contribute to our team and mission. Join us in shaping the future of our company and making a real impact every day.
What We Offer:
Salary Range for the Role 306000 - 343000 USD
Clinical-stage antibody therapies for psoriasis
Oruka Therapeutics develops antibody-based therapies for chronic skin diseases, focusing on plaque psoriasis and psoriatic arthritis. Its monoclonal antibodies, discovered and engineered by Paragon Therapeutics, are designed for longer dosing intervals to improve patient convenience. ORKA-001 targets IL-23p19 with an extended half-life that could allow dosing once or twice a year, while ORKA-002 targets IL-17A/F with dosing two to three times per year; both are in early-stage trials with Phase 2 planned for 2025–2026. The company aims to deliver higher skin clearance and durable remission to the large patient pool, pursuing commercialization after advancing through clinical trials; it entered public markets via a 2024 reverse merger with ARCA biopharma and raised over $475 million to fund operations through 2027.
Explore more opportunities at Oruka Therapeutics